4
Changes in Ownership
PULSE BIOSCIENCES, INC. Filed Acc 0001437749-26-003840
Chief Commercial Officer sold 60,000 shares at an average $23.39 ($1,403,400)
- Chief Commercial Officer acquired 60,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-09 | Option exercise 10b5-1 | +20,000 | $1.53 | $30,600 | 63,298 | D: show line 1 in the form |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-09 | Sale 10b5-1 | −20,000 | $21.45 | $429,000 | 43,298 | D: show line 2 in the form |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-10 | Option exercise 10b5-1 | +20,000 | $1.53 | $30,600 | 63,298 | D: show line 3 in the form |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-10 | Sale 10b5-1 | −20,000 | $23.52 | $470,400 | 43,298 | D: show line 4 in the form |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-11 | Option exercise 10b5-1 | +20,000 | $1.53 | $30,600 | 63,298 | D: show line 5 in the form |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-11 | Sale 10b5-1 | −20,000 | $25.20 | $504,000 | 43,298 | D: show line 6 in the form |
| Open-market sales · 60,000 sh · avg $23.39 · $1,403,400 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-09 | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 405,000 | D: show line 7 in the form | |||||
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-10 | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 385,000 | D: show line 8 in the form | |||||
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-11 | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 365,000 | D: show line 9 in the form |
Loading xslF345X05/rdgdoc.xml…